Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Emiliya Melkumova"'
Autor:
Enzo G. Plaitano, Rebecca A. Scharf, Pakinam E. Aboutaleb, Andrea L. Glennon, Emiliya Melkumova, Deborah M. Green-LaRoche
Publikováno v:
BMC Neurology, Vol 24, Iss 1, Pp 1-13 (2024)
Abstract Background Amantadine hydrochloride has been increasingly prescribed as a neurostimulant for neurocritical care stroke patients to promote wakefulness during inpatient recovery. However, a lack of guidelines makes it difficult to decide who
Externí odkaz:
https://doaj.org/article/114891d60a26462c992ce4de7bedfafd
Autor:
Emiliya Melkumova, David E. Thaler
Publikováno v:
Interventional Cardiology Clinics. 6:487-493
Stroke is a devastating condition. It is the fifth leading cause of death in the United States, and a leading cause of serious long-term disability. Stroke occurs at any age. Younger patients tend to have strokes of undetermined cause, termed cryptog
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b20a4d7ce455c91f8d546d82abed641f
https://doi.org/10.1016/j.iccl.2017.05.005
https://doi.org/10.1016/j.iccl.2017.05.005
Publikováno v:
JAMA neurology. 74(10)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d0abd96bd0c419acf7ad0791be25ffd
https://pubmed.ncbi.nlm.nih.gov/28828467
https://pubmed.ncbi.nlm.nih.gov/28828467
Publikováno v:
Stroke. 44
Background: ‘Clinical-diffusion mismatch’ (CDM) criteria may identify ischemic stroke (IS) patients with salvageable penumbra, and is intended for triage in a planned prospective trial of acute stroke intervention for patients presenting between
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ad2034e9fdebbbfff2d5ce48c53709a8
https://doi.org/10.1161/str.44.suppl_1.awp43
https://doi.org/10.1161/str.44.suppl_1.awp43
Autor:
Nazli Janjua, Emiliya Melkumova, Shamrez Akrem, Saqib Chaudhry, Haithem Hussain, Darwin Ramirez-Abreu, Rebecca Poleshuck, Sherene McIntyre, Wajahat Abbas, Toby I Gropen, Adnan I Qureshi
Publikováno v:
Stroke. 43
BACKGROUND: Intravenous tissue plasminogen activator (IV tPA) has established benefit in the treatment of acute ischemic stroke (AIS) among selected patients. Intra-arterial (IA) thrombolysis, though still of unproven efficacy, is postulated to have
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::629c9b24ce0ee402015f1f504c1eda46
https://doi.org/10.1161/str.43.suppl_1.a3301
https://doi.org/10.1161/str.43.suppl_1.a3301